123.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$121.53
Offen:
$121.43
24-Stunden-Volumen:
952.54K
Relative Volume:
1.19
Marktkapitalisierung:
$8.84B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
11.52
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
+3.92%
1M Leistung:
-5.61%
6M Leistung:
-14.08%
1J Leistung:
-17.74%
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
123.69 | 8.58B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
476.61 | 107.56B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
205.26 | 17.95B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.00 | 14.09B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
229.23 | 14.41B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
115.27 | 11.58B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc.’s volatility index tracking explainedVolume Spike & Precise Buy Zone Identification - newser.com
Can DaVita Inc. stock maintain operating marginsPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Sentiment analysis tools applied to DaVita Inc.Weekly Trend Summary & Daily Volume Surge Signals - newser.com
Is DaVita Inc. (TRL) stock testing key supportMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Can DaVita Inc. (TRL) stock retain market dominanceMarket Performance Recap & Consistent Profit Alerts - newser.com
Is DaVita Inc. (TRL) stock safe for risk averse investorsBond Market & Safe Entry Point Alerts - newser.com
Using AI based signals to follow DaVita Inc.July 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com
Will DaVita Inc. stock deliver better than expected guidanceJuly 2025 Update & High Conviction Buy Zone Alerts - Fundação Cultural do Pará
Why analysts maintain buy rating on DaVita Inc. (TRL) stock2025 Risk Factors & Verified Momentum Watchlists - fcp.pa.gov.br
Is DaVita Inc. stock a good choice for value investorsJuly 2025 Institutional & Reliable Price Action Trade Plans - Fundação Cultural do Pará
Is DaVita Inc. stock a buy on weakness2025 Biggest Moves & Scalable Portfolio Growth Ideas - fcp.pa.gov.br
Has DaVita Inc. formed a bullish divergenceWeekly Risk Report & Accurate Technical Buy Alerts - newser.com
How to integrate DaVita Inc. into portfolio analysis tools2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
Will DaVita Inc. stock outperform tech sector in 20252025 Pullback Review & Free Growth Oriented Trading Recommendations - newser.com
Can DaVita Inc. (TRL) stock attract ESG investmentsTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Can DaVita Inc. stock beat market expectations this quarterJuly 2025 Recap & Fast Entry Momentum Alerts - newser.com
Is DaVita Inc. stock safe for conservative investorsEarnings Trend Report & Scalable Portfolio Growth Methods - newser.com
DaVita Inc. (DVA) Stock forecasts - Yahoo! Finance UK
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
Will DaVita Inc. rebound enough to break evenStop Loss & Verified Stock Trade Ideas - newser.com
Is DaVita Inc. stock trading at a premium valuation2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Is a relief rally coming for DaVita Inc. holdersMarket Growth Report & Community Verified Trade Alerts - newser.com
Will DaVita Inc. stock profit from fiscal stimulus2025 Year in Review & Daily Momentum Trading Reports - newser.com
Is DaVita (NYSE:DVA) Using Too Much Debt? - 富途牛牛
DaVita Inc. $DVA Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
DaVita Inc. $DVA Position Increased by Strs Ohio - MarketBeat
DaVita’s Q3 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
TD Cowen Lowers DaVita (NYSE:DVA) Price Target to $133.00 - MarketBeat
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025 - PR Newswire
Technical analysis overview for DaVita Inc. stock2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
DaVita Reveals Its Developments Towards ESG Goals in Its Community Care Report - MSN
iA Global Asset Management Inc. Sells 6,594 Shares of DaVita Inc. $DVA - MarketBeat
Y Intercept Hong Kong Ltd Takes $1.24 Million Position in DaVita Inc. $DVA - MarketBeat
Custom strategy builders for tracking DaVita Inc.IPO Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
The Heart-Body Connection: How Other Organ Systems Affect Heart Health - GlobeNewswire Inc.
Oversold Conditions For DaVita (DVA) - Nasdaq
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):